Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-26 @ 12:36 AM
Study NCT ID:
NCT03427060
Status:
COMPLETED
Last Update Posted:
2025-05-04
First Post:
2018-01-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Sponsor:
AKARI Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-03
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-24
First Submit QC Date:
None
Study First Post Date:
2018-02-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-10
Results First Submit QC Date:
None
Results First Post Date:
2025-05-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-17
Last Update Post Date:
2025-05-04
Last Update Post Date Type:
ACTUAL